企业QQ
官方微信
OneLambda公司由移植学研究权威PaulTerasaki博士于1984年创建，加入赛默飞前是全球移植诊断领域的领军企业。其诊断测试被众多移植中心用于组织分类研究，主要为在移植手术前测试器官捐献者与接受者的匹配程度，并测试接受者体内是否存有可能导致排异反应的抗体。OneLambda约有员工320名，公司总部位于美国加利福尼亚州的CanogaPark，向全世界超过1400个实验室提供服务。2011年，该公司营业收入达1.82亿美元。
As a brand of Thermo Fisher Scientific, our commitment is to provide the most consistent and reliable reagents. The driving force behind our product development and educational programs is facilitating a new standard of care in transplant monitoring. We develop and distribute a comprehensive line of HLA typing and antibody detection products, laboratory instrumentation, and computer software that are used to simplify and automate testing procedures and final test evaluations. Our diagnostic tests are used by transplant centers worldwide to determine the compatibility of donors and recipients pre-transplant, and post-transplant to detect the presence of antibodies that can lead to transplant rejection.